Dr. P. K. Das

Monday - Saturday 09:00 - 17:00

Sunday - CLOSED

Official Address

Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, Delhi 110076

Monday - Friday 08:00 - 20:00

Saturday and Sunday - CLOSED

+91 98104 44600
Official Address

Indraprastha Apollo Hospitals

Follow Us



Dr. P.K. Das is a distinguished medical oncologist and hematologist with one of the most advanced and comprehensive cancer centers in Delhi, NCR. He is renowned as the best oncologist in Delhi NCR. His patients have access to a full range of services, including screening, diagnostics, treatment, follow-up tests, holistic and supportive care.

Employing high-end cancer diagnosis and precision treatments methods, he & his team are one of the most sought-after cancer treatment providers in Delhi, NCR. 

Dedicated to critical cancer treatment, control, prevention, and after-care, he has a team of highly motivated medical professionals working tirelessly to bridge the gap between cancer patients (both late & early-stage cancer) and the latest treatment, technology, research, screening, and prevention.


The mission is to deliver high-quality, latest, and most affordable healthcare services to ALL cancer patients through innovation, efficiency, compassion, accountability, respect for all, and excellence at all stages. Here you get long-term value and the ultimate cancer care modules.

Why is the service of an oncologist needed?

Cancer management is layered. It requires screening, diagnosis, staging, a strictly personalized cancer treatment procured through one of the best medical oncologists in Delhi, after-care, and support. With all this and more, Dr. P.K. Das performs thousands of procedures regularly abreast with well-thought-out strategies and great results. 

The suitability of a treatment plan depends on several factors; the most prima facie of those are general health, age, gender, physical fitness, and other medical conditions. He and his team help use an in-depth customized procedure to map out a plan and put the tumor/cancer under scrutiny before taking any step-be it deciding on a treatment or support or even diagnosis plan. 

Being the best cancer specialist doctor in Delhi, Dr. P.K. Das is trusted for the capacity to treat all malignancies irrespective of the complexity, grade, general health, age, gender, or other considerable factors. He has ventured into the latest and most advanced treatments aided by the best available technology in the market. 

The ability to lead not only in treatment and technology but also in current clinical trials and research has made Dr. P.K. Das one of the most reliable cancer doctors in Delhi

Medical Oncologist-What does that mean?

As a medical oncologist, Dr. P.K. Das specializes in the systemic therapy & treatment of cancer. The goal is to ensure that for each patient, the cancer is either permanently cured or controlled to the greatest length possible. This is done by avoiding cookie-cutter treatment plans and choosing personalized treatment plans that provide maximum benefits with minimum side effects. Some common medical oncology-related treatments include chemotherapy, targeted therapy, hormone therapy, and immunotherapy. If you want more information about the therapies, you can see them here. 

Hematologist-What does that mean?

As a hematologist, Dr. P.K. Das specializes in diseases of the blood and blood components. This includes blood & bone marrow cells. This helps diagnose anemia, infection, hemophilia, blood-clotting disorders, and leukemia.

Know your Doctor: Because Knowing is always better

Dr. P.K. Das is a top oncologist in Delhi, India. With 20+ years as an oncologist/hematologist, he is a Senior Medical Oncologist at Apollo Hospital, Sarita Vihar, New Delhi. He joined as Senior Consultant in Medical Oncology and Haemato Oncology and is currently engaged in several adjoined roles, including Academic Coordinator (Department Of Medical Oncology, Apollo Cancer Institute New Delhi), Visiting Senior Consultant Medical And Haemato- Oncologist (RAK Hospital, UAE), and Visiting Senior Consultant Medical And Haemato- Oncologist ( Apollo Hospital, Bhubaneswar).

The esteemed doctor completed his MBBS from VSS Medical College, Sambalpur University, Orissa. He did his internship at SCB Medical College, Cuttack, Orissa. Then, he went on to do an MD (Internal Medicine) from MKCG medical college Berhampur University, Orissa. The renowned oncologist then did a DM (Medical Oncology) from IRCH, AIIMS, New Delhi. Then he did fellowship training in advanced hemato-oncology treatment and bone marrow transplant at Peter–Mac Cancer Center, Melbourne, Australia. 

Since then, the award-winning oncologist has been a part of multiple research teams, helped treat thousands of cancer patients, lent a hand in many innovative cancer treatment approaches, taught many students (both nursing staff and doctors), and conducted multiple cancer screening, awareness camps. 

Being a hematologist and the best medical oncologist in Delhi, his key areas of interest in the field of oncology include blood cancers, breast cancer, lung cancer, brain tumor, gynecological cancers, and more. He is also passionate about health, fitness, and hence, he is an avid motivational speaker for cancer awareness & the role of exercise in beating, treating, avoiding cancer. 

Dr. P.K. Das has published multiple papers on various types of cancers and their intricacies. From lymphoma to lung cancer to breast cancer, he has put forward many studies intended to have a better look at cancer and help out as many people as possible. 

(Check out the publications HERE.)

Awards & Accolades

  • Nominated for Medical Excellence Award for excellence in the field of Oncology in India by Harvard Medical International Community Service. (From Harvard Medical School)

  • Organizing cancer awareness camps at various schools, colleges, universities, and corporate houses at regular intervals for the past ten years.

  • Conducting seminars in different parts of India & teaching general practitioners about the importance of cancer screening, early diagnosis, and prevention.

As an experienced provider of the best cancer treatment in Delhi NCR, Dr. P.K. Das’s aim is not just to be a doctor. The goal is to be a partner, a friend in need, and a patient advocate all at once.

If you need more information or a consultation…

If you need more information or help, this website can act as an informational resource. Find information about different types of cancer and their subsequent treatments here. If you or your loved ones have been diagnosed with cancer or suspect a cancer diagnosis, please consult Dr. P.K. Das. 

Better care, better health, better support; because you deserve more.

  • Role of recombinant erythropoietin in treatment of anemia in chronic renal failure was presented in the Conference of Association of Physicians of India Behampur, (ORISSA)
  • Role of circulating micromegakaryocytes in CML: Presented as a poster in the 11th International Congress on anti-cancer treatment held in February 2001 at Paris (France) and was awarded first prize. This work as been done for the first time in India
  • Disseminated fungal infection complicated with pulmonary haemorrhage in a case of acute myeloid leukaemia: A case report published in post graduate Medical Journal 2000 Vol 76, Pg 704-709
  • Extrosseous ewing’s sarcoma of the kidney: A case report published in Urologic internationals in June 2001
  • Oncoprotien C-erbB-2 in squamous cell carcinoma of uterine cervix and evaluation of its significant in response to treatment presented as a poster in the ASCO_PAN ASIA Cancer Conference held in February 20025 at New Delhi
  • Analysis of risk factors and cytogenetic anomalies in North Indian Leukemia Patients- Accepted for, Publication in Indian Journal of Medical Research in Oct 2005
  • Brain Tumor and Gliadel wafer treatment: Published in- Indian Journal of Cancer, Panigrahi M, DAS P.K. et al. Jan-March 2011/volume 48, Issue 1/ page 11-17/
  • Fibro lamellar Carcinoma of liver in an elderly patient: A unique Case report- Dr. P.K.Das, Dr. M. Bhadauria – accepted for publication in Indian journal of Cancer
  • Lapatinib use for Brain Metastases in HER 2- Positive Metastatic Breast Cancer : ( Abstract :167 )
  • A case report Published in –the Oncologist, Aug 2010, page 127-129
  • Two cases of NK/T cell Lymphoma presenting as Chronic Rhino sinusitis: Published in Indian Journal of Hematology and Blood Transfusion, July 2016, page 21-28
  • Cetuximab in the treatment of a patient with head and neck cancer with Squamous cell carcinoma: A case report published in July 2016 (Case report in oncological medicine).
  • Primary renal cell lymphoma: Case report and suggestions for diagnosis and management. Published in July 2016 (Indian Journals of hematology and blood transfusion)
  • Epidemiological study to evaluate the prevalence of epidermal growth factor receptor (EGFR) mutation status in NSCLC in India. Published (Asian Journal of Oncology).
  • Reliability of 18F- FDG PET metastatic parameters in simultaneous PET /MRI in prognostication of invasive ductal carcinoma: A feasibility study. Publication American Journal of Roentgenology in September 2017.
  • Evaluation of Chemotherapy response in locally advanced breast Cancer with simultaneous PET/MRI using pharmacokinetic, semi Quantitative and metabolic parameters. Publication in European Journal of Radiology in July 2018.

He is respected globally as an Senior Consultant in Oncology. He has delivered various Guest Speaker lectures Globally, addressing august gatherings, at venues, as per the years, specified below:-


  • Chaired session on Breast Cancer Treatment in “Cancer Scenario – 2006“, held at Faridabad for IMA, Faridabad on 12.8.2006
  • Conducted CME on – Breast Cancer, Treatment -Recent Advances in “Breast Cancer Summit”, held at Chandigarh on 14.10.2006
  • He represented India as a Senior Haemato-Oncologist in “Lymphoma Forum of Excellence”: “LYFE” meeting held at London on 7th – 8th November, 2006
  • Conducted CME -on “Recent advances in Multiple Myeloma Management” at Indian Medical Association meeting held at Faridabad on 11.08.2007
  • Was Guest Speaker & delivered lecture on “Lung Cancer Treatment – Paradigm shift” at Oncology Update held at Bhubaneswar on 27.12.2007
  • Was Guest Speaker & delivered a talk in the session on “Role of Targeted Treatment in Colorectal Cancer Management”, held at 7th International Conference RGCON – 2008 at Delhi on 08.03.2008
  • Delivered a talk on “Breast Cancer Scenario 2008″ organised by Breast Cancer Foundation, an NGO, held at Jammu on 23.03.2008
  • Was invited as Guest Speaker in the session – “Breast Cancer Treatment” in Himalayan Cancer Congress, 2008, organised by Breast Cancer Foundation (NGO), at Kabul, Afghanistan on 01.08.2008
  • Have delivered a talk on “MDS – Management” in 1st National update on Myelodysplastic Syndrome, at Mumbai on 03.07.2008
  • Delivered a talk on “Recent Advances in Multiple Myeloma Treatment” organised by Indian Society of Hematology and Transfusion Medicine – Golden Jubilee Conference, held at AIIMS, New Delhi on 24.11.2009
  • Chaired a session on “Chronic Myeloid Leukemia Management”– held in Oncology Advanced Scientific Summit (OASIS), 2009
  • Delivered a talk as Panel Speaker on “Advances in the treatment of MCRC” held at Delhi on 05.01.2010
  • Was a Panel Speaker in Symposia “Clinical Evidence in Customizing Treatment for NSCLC” held in Delhi on 18.07.2010
  • Have been a Faculty and Guest Speaker on “Advances in RCC Management – Role of Targeted Treatment” held at Delhi on 01.10.2010
  • Delivered a talk as Panel Speaker, on “Ovarian Cancer Treatment – Recent Advances” in FORCE, 2011, held at Phuket, Thailand on 18.02.2011
  • Trained for Executive Educational Programme on “Transformational Leadership for Healthcare Management” at Indian School of Business (ISB, Hyderabad) 25.06.2011 – 26.06.2011
  • Published and circulated widely, free of cost, since 2007-2008, a handbook of “100 answers to your questions about Cancer” by Dr. Das
  • Presented a talk on Role of Liposomal Doxorubicin in Metastatic Breast Cancer at SUN Oncology Update held in Goa on 21- 22 Oct 2011
  • Addressed Indian Medical Association (Jaipur) & conducted CME – Recent Advances in Lung Cancer Management on behalf of Apollo Hospital New Delhi on 29- Oct. 2011
  • Delivered a radio talk on Cancer Awareness on 93.5 FM Radio channel on World Cancer Day on 4th Feb. 2012
  • Conducted a Cancer Awareness workshop for corporate group HCL (Hindustan Computer) on 6-02-2012 their Headquarter based in Manesar, Gurgaon
  • Delivered a talk on the recent advances on management of Hormone refractory prostate cancer organized by Sanofi Oncology group ON 23-02- 2012 held at hotel Oberoi, New Delhi
  • Conducted CME on – Evolution of chemotherapy , Paradigm shift ,held by Indian Medical association Dehradun on 26-02-2012
  • Represented India & delivered a talk on – Multiple Myeloma , Indian scenario , held at Singapore on 02- 03 -2012
  • Chaired a session on Lung Cancer management on 13-03- 2012 held at 2nd Annual European society of Medical Oncology summit , New Delhi, Organized by Abbott’s Oncology India
  • Attended EGFR Advisors’ Network Meeting (EAN) from July 6-7- 2012, CopenHagen, Denmark
  • Delivered a talk on management of febrile neutropenia , role of G-CSF , Peg G- CSF & fungal infection in oncology practice, held at Shenzhen, China on 21-07-2012
  • Delivered a live talk show on” FREEDOM FROM CANCER” in Delhi AJTAK TV on 15th aug 2012, on the eve of 65th Indian Independence day celebration
  • Delivered a talk on Evolution of Modern chemotherapy and cancer association at Physician Forum and Nursing home Association (Faridabad) Meet, held on 31 Jan 2012
  • Delivered a talk as speaker on “Pregnancy Associated Breast Cancer “ at Sant Parmanand Hospital New Delhi Organized by Indian Menopausal Society New Delhi
  • Recently he has been appointed Member – Expert Advisory Committee (Oncology), Ministry of Health and Family Welfare, Govt. of India in Feb 2013
  • Addressed as a member of 1st Torrent Oncology. Advisory Team (TAT) meeting held at Torrent Research Centre, Ahmadabad held on 7.07.2013
  • Delivered a talk on” Role of targeted chemotherapy in Lung Cancer, Indian experience in East Asia NSCLC Scientific exchange conference held at Bangkok, Thailand on 24-25 August 2013
  • Delivered a talk on” Role of Liposomal Doxorubicin in the management of Metastatic Breast Cancer, organized by Sun Oncology, ESM held at Kolam, Kerla on 20-21st December 2013
  • Delivered a talk on” ALK Positive Non Small Cell Lung Cancer, Indian Experience” held on 7-9th Feb 2014, Apollo Cancer Conclave 2014 at ITC Grand Chola Chennai, India
  • Conducted a health talk Programme& Cancer awareness Campaign at Gymkhanna Club, Faridabad on 23.3.2014.
  • Delivered a CME talk on: Paradigm shift in advanced lung cancer management at Agra on 27th April 2014 organized by Indian Association of Clinical Medicines Agra.
  • Delivered a Lecture in CME: Evolution of modern Chemotherapy in cancer management on 21st May 2014 organized by NALCO, NTPC, COAL INDIA and Jindal steel Industries, ANGUL, ODISHA.
  • Conducted a CME & Cancer awareness Campaign at Puri, Odisha on 24th May 2014 organized by IMA, Puri.
  • Conducted a health talk , Cancer awareness and Anti Tobacco Campaign on 31st May 2014 on the eve of World no Tobacco day, Organized by Panacea Biotech, New Delhi
  • Conducted a CME on Evolution of modern Chemotherapy on 30th July 2014 at Rishikesh, Organised by IMA Muradabad.
  • Delivered a lecture on Recent advance on Cancer treatment on 23rd August 2014, held at ONGC Corporate office, C.P. New Delhi.
  • Conducted a Health talk programme & Cancer Awareness campaign on 22nd Oct 2014. Organized by FORE School of management, Qutab Institutional area, New Delhi.
  • Chaired a session on Lung Cancer treatment on 25th November 2014 Organized by SAARC federation of oncologist, held at New Delhi.
  • Delivered a lecture on Recent advances on treatment of Radioiodine Refractory Thyroid Cancer held on 24.1.2015 at Taipei, Taiwan, Organized by Eisai Oncology Group, Japan.
  • Delivered a talk on “Role of TKI’S in the management of chronic Myeloid Leukemia”, held on 6.02.2015, Apollo Cancer Conclave 2015 at HICC Hyderabad.
  • Health talk on Breast Cancer Awareness aired on World Cancer Day 16-02-2016 conducted by Door-Darshan National TV Channel.
  • Delivered Cancer awareness talk on World No Tobacco Day on 31-05-2016, aired on RED FM (93.5) radio channel.
  • Delivered A Talk on Indian experience of Palbociclib organized by Pfizer oncology in Mussoorie on 27th of August 2016
  • I have been consulted by global pharma-giants for conducting specialized research and education for the research, development and growth of medicines for curing The Emperor Of All The Maladies – Cancer



  • Selected as a member, Expert Advisory Committee on Oncology for the Six new upcoming AIIMS at Bhopal, Bhubaneswar, Jodhpur, Patna, Raipur and Rishikesh, under ministry of Health & Welfare, Family Govt of India


  • Selected as an Expert committee member of Drug Controller General of India
  • Member American Society of Clinical Oncology. (Since 2000)
  • Life member European Society of Medical Oncology.(Since 2012)
  • Lifetime member of ISMPO (Indian Society of Medical and Pediatric Oncology))


  • Role of circulating micromegakaryocytes in Chronic Myeloid Leukemia
  • Response of CHOP chemotherapy in Intermediate and high grade Non Hodgkin’s Lymphoma
  • To evaluate the efficacy of Sorafenib tosylate and Paclitaxel by measuring tumor response, as defined by RECIST criteria, in patients with metastatic, Her-2 Negative Breast Cancer.( P.I)
  • Role of IV FOSPREPITANT in prevention of chemotherapy induced nausea & vomiting (PI )
  • A Randomized two –arm , open – label multicenter Phase 2 trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab plus an aromatase inhibitor in first line patients with HER2- positive and hormone receptor – positive advanced ( metastatic or locally advanced) breast cancer (PI)
  • Epidemiological study to evaluate the prevalence of epidermal growth factor receptor ( EGGR) mutation status in Non- Small Cell Lung Cancer ( P.I.)
  • A Phase III Multicenter, Randomized Study of Oral LDK378 Vs. Standard Chemotherapy in previously untreated adult patients with ALK rearranged (ALK-positive), Stage IIIB or IV, Non-Squamous Non-Small Cell Lung Cancer (P.I.)
  • A Phase 3, Double blind, randomized, parallel group active controlled study to compare the efficacy and safety of CT-P6 versus Herceptin as Neoadjuvant and Adjuvant treatment in patients with Her2-positive Early Breast Cancer (Co. Investigator)
  • A Phase III, randomized, double blind, active controlled, parallel group study, conducted under in-house blinding conditions, to examine the safety, tolerability and efficacy of a single dose of intravenous MK-0517 for prevention of chemotherapy-induced nausea and vomiting. (P.I.)
  • A double blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib compared to placebo when administered in combination with Paclitaxel in patients with Locally Recurrent or Metastatic Breast Cancer. (P.I.)
  • A randomized, double blind, placebo controlled, multicenter Phase II Anamorelin HCl Dose Range study to evaluate the safety and efficacy of Anamorelin Hcl in Patients with NSCLC. (P.I.)
  • Post marketing (phase IV) trial to monitor the adverse events of Fosaprepitant (EMEND ® IV) in prevention of chemotherapy induced nausea vomiting (CINV) in patients receiving moderate or high emetogenic chemotherapy in usual practice in India. (P.I.))
  • An open label, multicenter, expanded treatment protocol (ETP) of oral LDK378 in adult patients with non-small cell lung cancer (NSCLC) characterized by ALK positivity. (P.I.)
  • Prospective single arm Post-Marketing Phase IV study to assess the safety and efficacy of Lenvatinib in subjects with Locally Recurrent or Metastatic, Progressive, Radioiodine Refractory Differentiated Thyroid cancer. ( P.I)
  • A phase II/III, pivotal, open label, randomized 3 arm study to assess safety and efficacy of LNP3794 monotherapy or in combination with Docetaxel, compared with Docetaxel alone, in patients with RAS mutation positive locally advanced and metastatic Non-Small Cell Lung Cancer. (P.I.)
  • A Phase study to investigate the safety & efficacy of Regorafenib in Indian Patients with Metastatic Colorectal Cancer (mCRC). ( P.I.)
  • A Prospective, Open- label, Phase 4 Study to Evaluate the Safety of Pembrolizumab ( KEYTRUDA (R) in Subjects with Unrespectable or Metastatic Melanoma or PDL-1 positive Non- Small Cell Lung Cancer (NSCLC) in India ( Keynote -593)“ (P.I.)
  • A Prospective, Single – arm , Multicenter, Pragmatic Phase- IV Trial Investigating safety and Effectiveness of DARZALEX ( Daratumumab) In Indian Subjects with Relapsed and Refractory Multiple Myeloma , whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent Protocol No: 54767414MMY4008 (P.I.)
  • A Prospective, Multicenter, Open –Label Single arm Phase- IV Clinical Trial to Assess the Safety of Lmbruvica Tm( Ibrutinib Capsules 140 mg ) in Indian patients with Chronic Lymphocytic Leukemia of Mantle Cell Lymphoma who have received at least one prior therapy or chronic Lymphocytic leukemia with 17p Deletion Protocol No : 54179060LYM4005 (P.I.)


  • Haematological malignancies
  • Chemotherapy in solid tumours